Accelr8 Technology Corporation
Accelr8 Announces Acceptance of Scientific Presentation, and Pilot Results with a New Rapid Test for a Major Emerging Resistance Threat
Published in Anti-Infectives Week, March 22nd, 2010
Accelr8 Technology Corporation (NYSE Amex: AXK) announced that it has received acceptance to present results for a study on 2-hour, culture-free, quantitative pathogen identification. The study was co-authored with principal investigators at the Denver Health Medical Center and the Barnes-Jewish Hospital in St. Louis. The presentation will take place at the 110th General Meeting of the American Society for Microbiology (ASM, www.asm.org) to be held from May 23-27 in San Diego. Tests performed directly from specimens accurately identified three target pathogens that are the most resistance-prone bacteria responsible for hospital-acquired infections (HAI).
The company...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Anti-Infectives Week
Source: Anti-Infectives Week (2010-03-22)
More Articles from Anti-Infectives Week
- Antiretrovirals
Study findings from University of Barcelona provide new insights into antiretrovirals - Apoptosis
Research on apoptosis described by H. Chen and colleagues - Breast Cancer
Reports outline breast cancer study results from Genentech, Inc. - Drug Resistance
New drug resistance study findings have been reported by scientists at Nagoya University, Medical Department - Drug Resistance
New findings from Central Hospital in the area of drug resistance published - Drug Resistance
Reports from University of Helsinki add new data to research in drug resistance - More from this issue of Anti-Infectives Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
